Reversion to sensitivity explains limited transmission of resistance in a hospital pathogen
Preprint
- 14 November 2024
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 13
Abstract
Bacterial pathogens that are successful in hospital environments must survive times of intense antibiotic exposure and times of no antibiotic exposure. When these organisms are closely associated with human hosts, they must also transmit from one patient to another for the resistance to spread. The resulting evolutionary dynamics have, in some settings, led to rising levels of resistance in hospitals. Here, we focus on an important but understudied aspect of this dynamic: the loss of resistance when the resistant organisms evolve in environments where the antibiotic pressure is removed. Based on prior data, we hypothesize that resistance arising in the context of strong selection may carry a high cost and revert to sensitivity quickly once the selective pressure is removed. Conversely, resistant isolates that persist through times of no antibiotic pressure should carry a lower cost and revert less quickly. To test this hypothesis, we utilize a genetically diverse set of patient-derived, daptomycin-resistant Enterococcus faecium isolates that include cases of both de novo emergence of resistance within patients and putatively transmitted resistance. Both of these sets of strains have survived periods of antibiotic exposure, but only putatively transmitted resistant strains have survived extended periods without antibiotic exposure. These strains were then allowed to evolve in antibiotic free laboratory conditions. We find that putatively transmitted resistant strains tended to have lower level resistance but that evolution in antibiotic-free conditions resulted in minimal loss of resistance. In contrast, resistance that arose de novo within patients was higher level but exhibited greater declines in resistance in vitro . Sequencing of the experimentally evolved isolates revealed that reversal of high level resistance resulted from evolutionary pathways that were frequently genetically associated with the unique resistance mutations of that strain. Thus, the rapid reversal of high-level resistance was associated with accessible evolutionary pathways where an increase in fitness is associated with decreased resistance. We describe how this rapid loss of resistance may limit the spread of resistance within the hospital and shape the diversity of resistance phenotypes across patients.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Quantifying acquisition and transmission of Enterococcus faecium using genomic surveillanceNature Microbiology, 2020
- Predicting microbial growth in a mixed culture from growth curve dataProceedings of the National Academy of Sciences, 2019
- trackViewer: a Bioconductor package for interactive and integrative visualization of multi-omics dataNature Methods, 2019
- Institution-wide and Within-Patient Evolution of Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium Bloodstream InfectionsInfection Control & Hospital Epidemiology, 2018
- Emergence of daptomycin non-susceptibility in colonizing vancomycin-resistant Enterococcus faecium isolates during daptomycin therapyInternational Journal of Medical Microbiology, 2015
- A framework for variation discovery and genotyping using next-generation DNA sequencing dataNature Genetics, 2011
- Inducible expression eliminates the fitness cost of vancomycin resistance in enterococciProceedings of the National Academy of Sciences, 2010
- Antibiotic resistance and its cost: is it possible to reverse resistance?Nature Reviews Microbiology, 2010
- Predicting Hospital Rates of Fluoroquinolone-Resistant Pseudomonas aeruginosa from Fluoroquinolone Use in US Hospitals and Their Surrounding CommunitiesClinical Infectious Diseases, 2004
- A dynamic approach to predicting bacterial growth in foodInternational Journal of Food Microbiology, 1994